Comparison of Pulsed Field Ablation with a Variable-Loop circular Catheter and vHPSD RF Ablation for PVI in atrial Fibrillation using a Near-Zero Fluoroscopy workflow

M. Borlich (Bad Segeberg)1, S. Groschke (Bad Segeberg)2, H. L. Phan (Bad Segeberg)2, J. Wietgrefe (Bad Segeberg)2, F. J. Hofmann (Bad Segeberg)2, S. Fichtlscherer (Bad Segeberg)2, H. Nef (Bad Segeberg)2, L. Iden (Bad Segeberg)1
1Segeberger Kliniken GmbH Herzzentrum Bad Segeberg, Deutschland; 2Segeberger Kliniken GmbH Herz- und Gefäßzentrum Bad Segeberg, Deutschland

COMPARISON OF PULSED FIELD ABLATION WITH A VARIABLE-LOOP CIRCULAR CATHETER AND VERY HIGH-POWER SHORT-DURATION RADIOFREQUENCY ABLATION FOR PULMONARY VEIN ISOLATION IN ATRIAL FIBRILLATION USING A NEAR-ZERO FLUOROSCOPY WORKFLOW: A RETROSPECTIVE SINGLE-CENTRE ANALYSIS

Background

Catheter ablation is an established therapy for atrial fibrillation (AF). Pulsed field ablation (PFA) and very high-power short-duration radiofrequency ablation with up to 90W (RFA) are established to achieve rapid and safe pulmonary vein isolation (PVI). Comparative data from a single center applying the same near-zero fluoroscopy workflow to both technologies are limited.

Objective

To retrospectively compare PFA via VLCC (VARIPULSE™) and high-power short-duration RFA (QDOT) for PVI with regard to procedural times, safety, and efficiency under a uniform near-zero fluoroscopy strategy.

Methods

We conducted a retrospective single-center analysis of the first 100 consecutive patients treated with PFA and the first 100 consecutive patients treated with QDOT-RFA to balance for learning-curves. Baseline characteristics were well balanced (p>0.05). The same near-zero fluoroscopy workflow based on 3D electroanatomical mapping was applied to both groups. Primary endpoints were acute complete PVI, total procedure time, and fluoroscopy parameters; secondary endpoints were periprocedural and in-hospital complications.

Results

Acute PVI was achieved in 100% of patients in both groups. Procedure times were short and clinically comparable (PFA 41 min vs RFA 44 min, p>0.05). Owing to the standardized near-zero fluoroscopy approach, fluoroscopy time and dose were low in both groups and did not differ significantly (p>0.05). No major procedure-related complications occurred; one clinically relevant access-site bleeding was observed in the RFA group.

Conclusion

In a single high-volume center using a uniform near-zero fluoroscopy workflow, both PFA and high-power short-duration RFA proved to be fast, safe, and efficient for PVI in AF. These findings support the use of either technology as a first-line (“first-do”) option when modern mapping-guided, low-radiation workflows are available. Long-term rhythm follow-up is warranted.



 Central illustration